167 related articles for article (PubMed ID: 24114065)
1. Vasospasm of labyrinthine artery in cerebellopontine angle surgery: evidence brought by distortion-product otoacoustic emissions.
Mom T; Montalban A; Khalil T; Gabrillargues J; Chazal J; Gilain L; Avan P
Eur Arch Otorhinolaryngol; 2014 Oct; 271(10):2627-35. PubMed ID: 24114065
[TBL] [Abstract][Full Text] [Related]
2. Intraoperative monitoring of cochlear function using distortion product otoacoustic emissions (DPOAEs) in patients with cerebellopontine angle tumors.
Morawski K; Namyslowski G; Lisowska G; Bazowski P; Kwiek S; Telischi FF
Otol Neurotol; 2004 Sep; 25(5):818-25. PubMed ID: 15354017
[TBL] [Abstract][Full Text] [Related]
3. Early effects of cerebellopontine angle compression on rabbit distortion-product otoacoustic emissions: a model for monitoring cochlear function during acoustic neuroma surgery.
Widick MP; Telischi FF; Lonsbury-Martin BL; Stagner BB
Otolaryngol Head Neck Surg; 1994 Oct; 111(4):407-16. PubMed ID: 7936673
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive intraoperative monitoring of cochlear function by cochlear microphonics during cerebellopontine-angle surgery.
Lourenço B; Madero B; Tringali S; Dubernard X; Khalil T; Chays A; Bazin A; Mom T; Avan P
Eur Arch Otorhinolaryngol; 2018 Jan; 275(1):59-69. PubMed ID: 29080147
[TBL] [Abstract][Full Text] [Related]
5. Vasospasm of the internal auditory artery: significance in cerebellopontine angle surgery.
Mom T; Telischi FF; Martin GK; Stagner BB; Lonsbury-Martin BL
Am J Otol; 2000 Sep; 21(5):735-42. PubMed ID: 10993468
[TBL] [Abstract][Full Text] [Related]
6. A model of real time monitoring of the cochlear function during an induced local ischemia.
Morawski K; Telischi FF; Niemczyk K
Hear Res; 2006 Feb; 212(1-2):117-27. PubMed ID: 16403609
[TBL] [Abstract][Full Text] [Related]
7. Hearing loss in vestibular schwannomas: analysis of cochlear function by means of distortion-product otoacoustic emissions.
Ferri GG; Modugno GC; Calbucci F; Ceroni AR; Pirodda A
Auris Nasus Larynx; 2009 Dec; 36(6):644-8. PubMed ID: 19419826
[TBL] [Abstract][Full Text] [Related]
8. Distortion-product otoacoustic emission tests evaluate cochlear function and differentiate cochlear and vestibular schwannoma.
Kagoya R; Shinogami M; Kohno M; Yamasoba T
Otolaryngol Head Neck Surg; 2013 Feb; 148(2):267-71. PubMed ID: 23197675
[TBL] [Abstract][Full Text] [Related]
9. Physiopathological significance of distortion-product otoacoustic emissions at 2f1-f2 produced by high- versus low-level stimuli.
Avan P; Bonfils P; Gilain L; Mom T
J Acoust Soc Am; 2003 Jan; 113(1):430-41. PubMed ID: 12558280
[TBL] [Abstract][Full Text] [Related]
10. Distortion-product otoacoustic emissions in nonacoustic tumors of the cerebellopontine angle.
Mobley SR; Odabasi O; Ahsan S; Martin G; Stagner B; Telischi FF
Otolaryngol Head Neck Surg; 2002 Feb; 126(2):115-20. PubMed ID: 11870339
[TBL] [Abstract][Full Text] [Related]
11. Monitoring cochlear function intraoperatively using distortion product otoacoustic emissions.
Telischi FF; Widick MP; Lonsbury-Martin BL; McCoy MJ
Am J Otol; 1995 Sep; 16(5):597-608. PubMed ID: 8588664
[TBL] [Abstract][Full Text] [Related]
12. An objective method of analyzing cochlear versus noncochlear patterns of distortion-product otoacoustic emissions in patients with acoustic neuromas.
Telischi F
Laryngoscope; 2000 Apr; 110(4):553-62. PubMed ID: 10763999
[TBL] [Abstract][Full Text] [Related]
13. Intracochlear signal in FIESTA-C and hearings of patients with cerebellopontine angle schwannoma.
Kitamura M; Oishi N; Nishiyama T; Hosoya M; Hasebe N; Tsuzuki N; Ogawa K
Acta Otolaryngol; 2023 Jan; 143(1):19-23. PubMed ID: 36661412
[TBL] [Abstract][Full Text] [Related]
14. Preventing internal auditory artery vasospasm using topical papaverine: an animal study.
Morawski K; Telischi FF; Merchant F; Namyslowski G; Lisowska G; Lonsbury-Martin BL
Otol Neurotol; 2003 Nov; 24(6):918-26. PubMed ID: 14600475
[TBL] [Abstract][Full Text] [Related]
15. Deterioration in Distortion Product Otoacoustic Emissions in Auditory Neuropathy Patients With Distinct Clinical and Genetic Backgrounds.
Kitao K; Mutai H; Namba K; Morimoto N; Nakano A; Arimoto Y; Sugiuchi T; Masuda S; Okamoto Y; Morita N; Sakamoto H; Shintani T; Fukuda S; Kaga K; Matsunaga T
Ear Hear; 2019; 40(1):184-191. PubMed ID: 29688962
[TBL] [Abstract][Full Text] [Related]
16. Influence of primary frequencies ratio on distortion product otoacoustic emissions amplitude. II. Interrelations between multicomponent DPOAEs, tone-burst-evoked OAEs, and spontaneous OAEs.
Moulin A
J Acoust Soc Am; 2000 Mar; 107(3):1471-86. PubMed ID: 10738802
[TBL] [Abstract][Full Text] [Related]
17. [Otoacoustic emissions in clinical and surgical practice].
Mom T
Ann Otolaryngol Chir Cervicofac; 2007 Jun; 124(2):80-9. PubMed ID: 17336918
[TBL] [Abstract][Full Text] [Related]
18. Measuring the cochlear blood flow and distortion-product otoacoustic emissions during reversible cochlear ischemia: a rabbit model.
Mom T; Telischi FF; Martin GK; Lonsbury-Martin BL
Hear Res; 1999 Jul; 133(1-2):40-52. PubMed ID: 10416863
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the auditory-evoked brainstem response wave I to distortion-product otoacoustic emissions resulting from changes to inner ear blood flow.
Telischi FF; Mom T; Agrama M; Stagner BB; Ozdamar O; Bustillo A; Martin GK
Laryngoscope; 1999 Feb; 109(2 Pt 1):186-91. PubMed ID: 10890763
[TBL] [Abstract][Full Text] [Related]
20. Contralateral auditory stimulation alters acoustic distortion products in humans.
Moulin A; Collet L; Duclaux R
Hear Res; 1993 Feb; 65(1-2):193-210. PubMed ID: 8458751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
